Baidu
map

Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease: the APOKADO study

Zagnoli, F; Leblanc, A; Viakhireva-Dovganyuk, I; Delabrousse-Mayoux, JP; Pouyet, A; Ziegler, M; Sogni, L; Patat, M; Bouillot, R; Vérin, M

Vérin, M (通讯作者)，Pontchaillou Univ Hosp, Neurol Dept, Rue Henri Guilloux, F-35000 Rennes, France.;Vérin, M (通讯作者)，Inst Clin Neurosci Rennes, Rennes, France.;Vérin, M (通讯作者)，INSERM 1414, CIC IT, Behav & Basal Ganglia Res Unit, Rennes, France.;Vérin, M (通讯作者)，Univ Rennes, Rennes, France.

JOURNAL OF NEURAL TRANSMISSION, 2023; 130 (11): 1463

Abstract

Continuous subcutaneous apomorphine infusion (CSAI) is used to treat patients with Parkinson's disease (PD) who are experiencing motor fluctuations. H......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

Baidu
map
Baidu
map
Baidu
map